7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Cardio Diagnostics Holdings Inc
(NASDAQ:CDIO) 

CDIO stock logo

Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test ...

Founded: 2017
Sector: LIFE SCIENCES
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Healthcare
Share this website to your friends
Cardio Diagnostics Days Payable Outstanding ttm (DPO)
202311 202312 202401 202402 202403 202404 02.064.126.198.2510.3112.3714.43Thousand
Cardio Diagnostics Days Receivable Outstanding ttm (DSO)
202311 202312 202401 202402 202403 202404 0788.211,576.422,364.623,152.833,941.044,729.255,517.46
Cardio Diagnostics Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.65-1.41-1.18-0.94-0.71-0.47-0.240
Cardio Diagnostics Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.67-1.43-1.2-0.96-0.72-0.48-0.240
Cardio Diagnostics Cash Per Share ttm
202311 202312 202401 202402 202403 202404 00.190.380.570.760.951.141.33
Cardio Diagnostics P/S ratio ttm
202311 202312 202401 202402 202403 202404 07.114.1921.2928.3835.4842.5849.67Thousand
Cardio Diagnostics (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -2.75-2.35-1.96-1.57-1.18-0.78-0.390
Cardio Diagnostics P/B ratio ttm
202311 202312 202401 202402 202403 202404 01.63.24.796.397.999.5911.19
No extra charts and metrics for this ticker.